Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor

被引:42
作者
Dong, G [1 ]
Lee, TL [1 ]
Yeh, NT [1 ]
Geoghegan, J [1 ]
Van Waes, C [1 ]
Chen, Z [1 ]
机构
[1] Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, Tumor Biol Sect, NIH, Bethesda, MD 20892 USA
关键词
HGF/c-Met; angiogenesis; squamous cell carcinoma; metastasis; Gro-1/KC; VEGF;
D O I
10.1038/sj.onc.1207851
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously performed gene expression pro. ling in a multistep squamous cell carcinoma (SCC) progression model, and identified growth-regulated oncogene-1 (Gro1/KC) as a factor that contributes to enhanced angiogenesis, tumorigenesis and metastasis. In the present study, we explored molecular pathways coactivated with Gro-1/KC, and identified a transcript that encodes c-Met, the receptor for hepatocyte growth factor/scatter factor (HGF). Northern, Western blot, and immunohistochemical analyses confirm that expression of c-Met mRNA and protein is increased with SCC progression. In vitro, HGF preferentially promoted scattering in the metastatic LY-1 and LY-2 lines, and enhanced angiogenesis factors Gro-1/KC and vascular endothelial growth factor (VEGF) production by all tumor cell lines. In vivo, tumor growth and lung metastasis were promoted by transfection and overexpression of HGF cDNA in metastatic LY-1 cells. Our data indicate that metastatic SCC cells that overexpress c-Met exhibit angiogenesis factor expression and enhanced scattering in response to HGF in vitro, and tumorigenesis and metastasis in response to HGF in the tumor microenvironment in vivo.
引用
收藏
页码:6199 / 6208
页数:10
相关论文
共 53 条
  • [11] 2-U
  • [12] CROWLBANCROFT C, 2001, CLIN CANCER RES, V7, P435
  • [13] Dong G, 1999, CANCER RES, V59, P3495
  • [14] Dong G, 2001, CANCER RES, V61, P4797
  • [15] Dong G, 2001, CANCER RES, V61, P5911
  • [16] Duffey DC, 1999, CANCER RES, V59, P3468
  • [17] Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications
    Ferrara, N
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 10 - 14
  • [18] Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma
    Fukuura, T
    Miki, C
    Inoue, T
    Matsumoto, K
    Suzuki, H
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (04) : 454 - 459
  • [19] Independent prognostic value of serum hepatocyte growth factor in bladder cancer
    Gohji, K
    Nomi, M
    Niitani, Y
    Kitazawa, S
    Fujii, A
    Katsuoka, Y
    Nakajima, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2963 - 2971
  • [20] SCATTER FACTOR INDUCES BLOOD-VESSEL FORMATION INVIVO
    GRANT, DS
    KLEINMAN, HK
    GOLDBERG, ID
    BHARGAVA, MM
    NICKOLOFF, BJ
    KINSELLA, JL
    POLVERINI, P
    ROSEN, EM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1937 - 1941